Tools for Practice Outils pour la pratique


#385 Topical minoxidil for androgenetic alopecia: When blood pressure agents make you hairy


CLINICAL QUESTION
QUESTION CLINIQUE
How effective is topical minoxidil for androgenetic alopecia?


BOTTOM LINE
RÉSULTAT FINAL
In men and women, topical minoxidil improves hair density by about 21 hairs/cm2 versus 5-9 (placebo) after 16-48 weeks.  Oral and topical minoxidil are similarly effective albeit with different adverse effects. Finasteride is likely more effective than topical minoxidil in men.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Results statistically significant unless indicated.
  • One systematic review of randomized controlled trials (RCTs) with extractable data of topical minoxidil, past 5 years.1 After 16-48 weeks:
  • Women:
    • Versus placebo: 1
      • Additional hairs/cm2 over placebo: 12-14 (2-4 RCTs, 476-717 participants).
        • Example 21 additional hairs/cm2 minoxidil versus 9 (placebo).
    • Additional RCT topical versus oral minoxidil (52 participants): 2
      • 1mg oral versus topical 5% once-daily:
        • Additional hairs/cm2, global improvement: No difference.
  • Men:
    • Versus placebo: 1
      • Additional hairs/cm2 over placebo: 8-15 (4-10 RCTs, 598-1207 participants).
        • Example 21 versus 5 (placebo).
    • Additional RCT topical versus oral minoxidil (90 participants): 3
      • 5mg oral versus topical 5% twice-daily:
        • Additional hairs/cm2: No difference.
        • Proportion with improvement at vertex: 46% versus 70% (oral); no difference at frontal areas.
    • Additional RCTs topical minoxidil versus 1mg oral finasteride:
      • Topical 2% twice-daily (99 participants): 4
        • Additional hair/0.49cm2 (baseline: 61-65): 9.6 versus 18 (finasteride).
        • “Improvement”: No difference.
      • Topical 5% twice-daily (65 participants): 5
        • Improvement: 52% versus 80% (finasteride).
  • Adverse effects, examples:
    • Hypertrichosis (25% topical versus 49% oral),3 headaches (2% topical versus 14% oral).3 No meaningful changes in blood pressure/heart rate with oral.2,3
    • Scalp eczema (16% topical versus 2% oral).3
    • Shedding (9-16% oral/topical).3
    • Loss of libido 0% (minoxidil oral/topical) versus 15% (finasteride).5
  • Limitations: Clinical significance of hairs/cm2 unclear, few studies looking at patient satisfaction, RCTs often unblinded, mostly in 30-40 year-old men, high drop-out rates.

CONTEXT
CONTEXTE
  • Health-related quality-of-life impairments with androgenetic alopecia comparable/greater than acne vulgaris.6
  • In men, higher efficacy topical minoxidil with higher concentration: 19 additional hairs/cm2 (5%) versus 13 (2%), and patient assessment scores higher (51 on 100-point scale versus 41 for 2%).7
    • Severe scalp symptoms also higher with higher concentration: 4% versus 1%.
    • Inconsistent results in women.8


Luma Al-Dulaimi March 17, 2025

good to know that minoxidil used for 16-48 week to improve the outcome

Mike morris March 19, 2025

Oral finesteride best

ROBERT BRADSTOCK March 20, 2025

I agree with the concept that oral finasteride is more effective than topical minoxidil.

Jennifer Douek March 21, 2025

what are the cost differences between the treatments?

Hisham Elmahdi March 26, 2025

Any difference in velocity of hair loss after stopping minoxidil vs Finasteride?

tracy sullivan March 28, 2025

i am not keen on oral finasteride given. the risk of significant longterm side effects to men

Manjula Jeyapragasan March 29, 2025

Finasteride orally to be tried before topical minoxidil

David Hart April 1, 2025

Worth considering

Anwar Abu Dieh April 2, 2025

Always good results when po used

Brian McDermid April 15, 2025

ED is generally less common with topical Minoxidil yet less effective than oral Finasteride. A potentially bitter, but sometimes tolerable pill to swallow, requiring monitoring and medication change, if necessary.

Brian McDermid April 15, 2025

ED is generally less common with topical Minoxidil yet generally less effective than either oral Minoxidil or Finasteride. A potentially bitter, but sometimes tolerable pill to swallow, requiring monitoring and medication change, if necessary.


Latest Tools for Practice
Derniers outils pour la pratique

#387 Side effects of long-term PPI use: Leaving a bad taste in your mouth?

What are the side effects of long-term proton pump inhibitor (PPI) use?
Read Lire 0.25 credits available Crédits disponibles

#386 The Bland Supremacy: Salt and cardiovascular disease

Does reducing sodium intake or substituting table salt with sodium-potassium alternatives improve cardiovascular outcomes?
Read Lire 0.25 credits available Crédits disponibles

#385 Topical minoxidil for androgenetic alopecia: When blood pressure agents make you hairy

How effective is topical minoxidil for androgenetic alopecia?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Émélie Braschi MD PhD CCFP
  • Alexander Kiciak MD
  • Jennifer Young MD CCFP-EM

1. Gupta AK, Bamimore MA, Foley KA. J Dermatolog Treat. 2022 Feb;33(1):62-72.

2. Ramos PM, Sinclair RD, Kasprzak M et al. J Am Acad Dermatol. 2020 Jan;82(1) :252-253.

3. Penha M, Miot HA, Kasprzak M et al. JAMA Dermatol. 2024 Jun 1;160(6):600-5.

4. Sarawat A, Kumar B. Arch Dermatol. 2003 Sep;139(9):1219-21.

5. Arca E, Acikgoz G, Tastan HB et al. Dermatology. 2004;209(2):117-25.

6. Huang CH, Fu Y, Chi CC. JAMA Dermatol. 2021 Aug 1;157(8):963-970.

7. Olsen EA, Dunlap FE, Funicella T et al. J Am Acad Dermatol. 2002 Sep;47(3):377-85.

8. Lucky AW, Piacquadio DJ, Ditre CM et al. J Am Acad Dermatol. 2004 Apr;50(4):541-53.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.